Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-23 Purchase | 2022-06-27 06:41 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) | View |
| 2019-12-16 Purchase | 2019-12-18 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 20,000 | $5.0954 | $101,908 | 652,216 (Direct) | View |
| 2019-09-30 Purchase | 2019-10-02 07:36 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 8,710 | $5.6812 | $49,483 | 632,216 (Direct) | View |
| 2019-09-23 Purchase | 2019-09-25 07:40 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 8,680 | $5.8102 | $50,433 | 623,506 (Direct) | View |
| 2019-09-18 Purchase | 2019-09-20 07:37 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 14,288 | $5.9116 | $84,465 | 614,826 (Direct) | View |
| 2019-09-13 Purchase(A) | 2019-09-17 4:21 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 21,547 | $5.9149 | $127,449 | 600,538 (Direct) | View |
| 2019-09-13 Purchase | 2019-09-17 07:35 am | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 13,000 | $5.8454 | $75,990 | 591,991 (Direct) | View |
| 2019-09-09 Purchase | 2019-09-11 4:05 pm | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 20,000 | $5.1412 | $102,824 | 578,991 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-15 Option Award | 2022-07-19 4:34 pm | N/A N/A | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 604,308 | $0 | 604,308 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:15 pm | N/A 2032-06-17 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-04-27 Option Award | 2022-04-28 7:07 pm | N/A 2032-04-26 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 7:44 pm | N/A 2032-03-29 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 457,758 | $0 | 1,656,593 (Direct) | View |
| 2021-05-05 Option Award | 2021-07-23 6:15 pm | N/A 2031-05-04 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 4:14 pm | N/A 2031-06-04 | F-star Therapeutics Inc. | FSTX | Brady Todd C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-04-12 Option Award | 2021-04-14 7:23 pm | N/A 2031-04-11 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 296,619 | $0 | 1,198,835 (Direct) | View |
| 2020-11-19 Other | 2020-11-23 11:17 am | 2017-05-24 2021-11-23 | F-star Therapeutics Inc. | SBPH | Brady Todd C Director | 2,741 | $0 | 0 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 9,235 | $0 | 60,016 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 8,418 | $0 | 50,781 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-25 4:00 pm | N/A 2030-06-23 | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-05-27 Option Award | 2020-05-29 4:42 pm | N/A 2030-05-26 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 57,750 | $0 | 57,750 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-01 4:00 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 13,306 | $0 | 42,363 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 7:44 pm | N/A 2030-03-01 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 700,865 | $0 | 1,603,081 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-02 5:09 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 7,832 | $0 | 29,057 (Direct) | View |
| 2019-09-30 Option Award | 2019-10-01 4:47 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 3,597 | $0 | 21,225 (Direct) | View |
| 2019-07-10 Option Award | 2019-07-11 08:55 am | N/A 2029-07-09 | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2019-06-28 Option Award | 2019-07-01 09:00 am | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 3,354 | $0 | 17,628 (Direct) | View |
| 2019-05-02 Option Award | 2019-05-03 5:44 pm | N/A 2029-05-01 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2019-03-29 Option Award | 2019-04-02 4:03 pm | N/A N/A | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 1,180 | $0 | 14,274 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 5:20 pm | N/A 2029-03-04 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 295,329 | $0 | 851,383 (Direct) | View |
| 2018-06-18 Option Award | 2018-06-19 4:28 pm | N/A 2028-06-17 | Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director | 5,500 | $0 | 5,500 (Direct) | View |
| 2018-04-26 Option Award | 2018-04-27 4:22 pm | N/A 2028-04-25 | Evoke Pharma Inc | EVOK | Brady Todd C Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2018-03-06 Option Award | 2018-03-08 4:40 pm | N/A 2028-03-05 | Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO | 318,562 | $0 | 519,776 (Direct) | View |